Clearside Biomedical, Inc. (NASDAQ: CLSD) announced the pricing of its underwritten public offering of 6,538,462 shares of its common stock ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE